LIMN
Liminatus Pharma, Inc.
$0.14
+0.03 (+24.35%)
At close · Jul 2
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has concluded that there is substantial doubt about its ability to continue as a going concern for one year after the date that the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed May 15, 2026
Market Cap
$6.40M
Shares
44,877,633
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding LIMN
5 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | — | 50,440 | $8,671 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 27,254 | $6,895 | 0.00% | Long | 2026-02-28 | |
| Fidelity Nasdaq Composite Index Fund | — | 16,770 | $4,243 | 0.00% | Long | 2026-02-28 | |
| Fidelity Total Market Index Fund | — | 8,096 | $2,048 | 0.00% | Long | 2026-02-28 | |
| Fidelity Series Total Market Index Fund | — | 6,202 | $1,569 | 0.00% | Long | 2026-02-28 |
Showing 1–5 of 5 positions
Key facts
CIK
1971387
CUSIP
53271X108